[1]姚旻,赵爱源,李红涛,等.人体肥胖指数在评价2型糖尿病患者 肥胖中的应用价值[J].国际内分泌代谢杂志,2017,37(01):1-5.[doi:10.3760/cma.j.issn.1673-4157.2017.01.01]
　Yao Min*,Zhao Aiyuan,Li Hongtao,et al.Body adiposity index and its value in obesity evaluation in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(01):1-5.[doi:10.3760/cma.j.issn.1673-4157.2017.01.01]
点击复制

人体肥胖指数在评价2型糖尿病患者 肥胖中的应用价值()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年01期
页码:
1-5
栏目:
论著
出版日期:
2017-01-20

文章信息/Info

Title:
Body adiposity index and its value in obesity evaluation in patients with type 2 diabetes mellitus
作者:
姚旻; 赵爱源; 李红涛; 张晓会; 张宏
300070 天津医科大学代谢病医院内分泌研究所,卫生部激素与发育重点实验室(姚旻,张晓会,张宏); 300309 天津,武警后勤学院科研部(赵爱源); 300252 天津,武警天津总队医院内二科(姚旻,李红涛)
Author(s):
Yao Min*;  Zhao Aiyuan;  Li Hongtao;  Zhang Xiaohui;  Zhang Hong.
*Key Laboratory of Hormones and Development(Ministry of Health), The Metabolic Disease Hospital & Endocrinology Institute, Tianjin Medical University, Tianjin 300070, China
关键词:
人体肥胖指数;  2型糖尿病;  人体测量学指标;  肥胖症
Keywords:
Body adiposity index;  Type 2 diabetes mellitus;  Anthropometric parameter;  Obesity
DOI:
10.3760/cma.j.issn.1673-4157.2017.01.01
摘要:
目的 探讨人体肥胖指数(BAI)在评价2型糖尿病患者肥胖中的应用价值。方法 采用横断面研究,选取住院2型糖尿病患者428例(男219例,女209例),测量并计算体重指数、腰围、BAI、腰臀比、腰围身高比(WHtR),比较不同性别间各项人体测量学指标的差异,采用偏相关分析评价BAI与临床指标之间的关系。应用受试者工作特征(ROC)曲线,比较不同人体测量学指标诊断肥胖的曲线下面积(AUC)并确定BAI的理想切点值。结果 除体重指数外,腰围、BAI、腰臀比、WHtR在男性、女性患者间均有差异(t=-12.283～4.626,P均<0.01)。男性患者的BAI与收缩压、舒张压呈正相关,与高密度脂蛋白-胆固醇(HDL-C)呈负相关(r=0.172、0.164、-0.150,P均<0.05)。女性患者的BAI与HbA1c、舒张压呈正相关(r=0.194、0.142,P均<0.05)。ROC分析显示,在预测肥胖时,BAI的价值低于腰围及WHtR,在女性糖尿病患者中BAI的价值高于WHR(P均<0.05)。男性、女性患者预测肥胖的BAI切点值分别为 27.67和 31.52。结论 在2型糖尿病患者中,BAI值具有性别差异,可作为评价糖尿病人群肥胖的新人体测量学指标。仅女性患者中其诊断价值高于WHR。
Abstract:
Objective To investigate the clinical utility of body adiposity index(BAI)in evaluating obesity in patients with type 2 diabetes mellitus. Methods A cross-sectional study including 428 patients(219 male, 209 female)was conducted. The body mass index(BMI), waist circumference(WC), BAI, waist-to-hip ratio(WHR), waist-to-height ratio(WHtR)were collected and calculated. The differences of these anthropometric parameters between male and female were compared. Partial correlation analysis was used to evaluate the relationship between BAI and clinical indicators. Receiver operating characteristic(ROC)curve was used to compare the areas under the curve(AUC)of different anthropometric parameters in the diagnosis of obesity. The optimal cut-off value of BAI was also determined. Results Except BMI, there were significant differences of WC, BAI, WHR, WHtR between male and female patients(t=-12.283-4.626, all P<0.01). BAI was positively correlated with systolic blood pressure and diastolic blood pressure, and negatively correlated with high density lipoprotein-cholesterol in male patients(r=0.172, 0.164, -0.150, all P<0.05). BAI was positively correlated with HbA1c and diastolic blood pressure in female patients(r=0.194, 0.142, all P<0.05). ROC analysis revealed that BAI was inferior to WC and WHtR but was superior to WHR in prediction of obesity in female patients(all P<0.05). The optimal cut-off value of BAI to predict obesity was 27.67 in male patients and 31.52 in female patients. Conclusions There is difference in BAI between male and female patients with type 2 diabetes mellitus. BAI may be a new anthropometric parameter of obesity in patients with diabetes mellitus. The value of BAI to assess obesity is higher than WHR only in female patients.

参考文献/References:

[1] Ng M, Fleming T, Robinson M,et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2014,384(9945):766-781. DOI: 10.1016/S0140-6736(14)60460-8.
[2] Kodama S, Horikawa C, Fujihara K,et al. Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis[J].Am J Epidemiol,2012,176(11):959-969. DOI: 10.1093/aje/kws172.
[3] Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity[J].Obesity(Silver Spring),2011,19(5):1083-1089. DOI: 10.1038/oby.2011.38.
[4] Djibo DA, Araneta MR, Kritz-Silverstein D, et al. Body adiposity index as a risk factor for the metabolic syndrome in postmenopausal Caucasian, African American, and Filipina women[J].Diabetes Metab Syndr,2015,9(2):108-113. DOI: 10.1016/j.dsx.2014.04.011.
[5] García AI, Niño-Silva LA, González-Ruíz K, et al. Body adiposity index as marker of obesity and cardiovascular risk in adults from Bogotá, Colombia[J].Endocrinol Nutr,2015,62(3):130-137. DOI: 10.1016/j.endonu.2014.11.007.
[6] Alvim Rde O, Mourao-Junior CA, de Oliveira CM, et al. Body mass index, waist circumference, body adiposity index, and risk for type 2 diabetes in two populations in Brazil: general and Amerindian[J].PLoS One,2014,9(6):e100223. DOI: 10.1371/journal.pone.0100223.
[7] Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men[J].Diabetes Care,1994,17(9):961-969.
[8] Pasco JA, Holloway KL, Dobbins AG,et al. Body mass index and measures of body fat for defining obesity and underweight: a cross-sectional,population-based study[J].BMC Obes,2014,1:9. DOI: 10.1186/2052-9538-1-9.
[9] Scheen AJ, Van Gaal LF. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes[J].Lancet Diabetes Endocrinol,2014,2(11):911-922. DOI: 10.1016/S2213-8587(14)70004-X.
[10] 陶然, 徐燕, 苏健,等. 江苏省成年人肥胖测量指标与糖尿病患病风险的关系 [J]. 中华糖尿病杂志,2014,6(10): 742-747. DOI: 10.3760/cma.j.issn.1674-5809.2014.10.009.
[11] Godoy-Matos AF, Moreira RO, Valerio CM,et al. A new method for body fat evaluation, body adiposity index, is useful in women with familial partial lipodystrophy[J].Obesity(Silver Spring),2012,20(2):440-443. DOI: 10.1038/oby.2011.343.
[12] Dias IB, Panazzolo DG, Marques MF, et al. Relationships between emerging cardiovascular risk factors, z-BMI, waist circumference and body adiposity index(BAI)on adolescents[J].Clin Endocrinol(Oxf),2013,79(5):667-674. DOI: 10.1111/cen.12195.
[13] Melmer A, Lamina C, Tschoner A,et al. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors[J].Obesity(Silver Spring),2013,21(4):775-781. DOI: 10.1002/oby.20289.
[14] Schulze MB, Thorand B, Fritsche A,et al. Body adiposity index, body fat content and incidence of type 2 diabetes[J]. Diabetologia,2012,55(6):1660-1667. DOI: 10.1007/s00125-012-2499-z.
[15] 广东省糖尿病流行病学调查协作组. 腰围/身高比值:预测糖尿病和高血压的有效的腹型肥胖指标[J]. 中华内分泌代谢杂志, 2004, 20(3): 272-275. DOI: 10.3760/j.issn:1000-6699.2004.03.036.
[16] Moliner-Urdiales D, Artero EG, Sui X,et al. Body adiposity index and incident hypertension: the Aerobics Center Longitudinal Study[J].Nutr Metab Cardiovasc Dis,2014,24(9):969-975. DOI: 10.1016/j.numecd.2014.03.004.
[17] Chandra A, Neeland IJ, Berry JD,et al. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study[J].J Am Coll Cardiol,2014,64(10):997-1002. DOI: 10.1016/j.jacc.2014.05.057.
[18] Zhang ZQ, Liu YH, Xu Y,et al. The validity of the body adiposity index in predicting percentage body fat and cardiovascular risk factors among Chinese[J].Clin Endocrinol(Oxf), 2014,81(3):356-362. DOI: 10.1111/cen.12351.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
　Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(01):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
　Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(01):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
　Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
　Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
　Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
　Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(01):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
　Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(01):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
　Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(01):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
　Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(01):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
　Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(01):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
通信作者:张宏,Email:zh80008@163.com
更新日期/Last Update: 2017-01-20